• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Catalog Number RONYX20030X
Device Problem Fracture (1260)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/20/2018
Event Type  malfunction  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
During a procedure a resolute onyx rx coronary drug eluting stent was used to treat a lesion in the mid left anterior descending artery (lad).It was reported that a stent fracture (type 2) was noted post implantation of the stent.
 
Manufacturer Narrative
Image review: a short video was provided for analysis.The video appears to show a portion of a guide catheter with the subclavian artery.There is no evidence of a stent fracture in the short video provided.Additional information: the mid lad had 70% stenosis, moderate calcification, and moderate tortuosity.The lesion was pre-dilated.The resolute onyx was implanted to 16atm.The stent was post-dilated to 18atm.It was reported that a stent fracture (type 2) was noted post implantation of the stent, however, it was reported that no device malfunction occurred or is suspected.The patient was discharged the following day.The investigator reviewed the coronary images and disagreed about the stent fracture.There was a heavily calcified area at the middle part of the stent.Also, there is a small branch diagonal two artery draining across at the middle of the stent.The post dilatation balloon was expanded within the allowable limit of the stent.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE ONYX RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8752328
MDR Text Key149829306
Report Number9612164-2019-02632
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeMY
PMA/PMN Number
P160043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/26/2019
Device Catalogue NumberRONYX20030X
Device Lot Number0008811108
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/07/2019
Initial Date FDA Received07/02/2019
Supplement Dates Manufacturer Received07/05/2019
Supplement Dates FDA Received07/30/2019
Date Device Manufactured09/26/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age68 YR
Patient Weight61
-
-